UpHealth, Inc. (UPH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UpHealth, Inc. (UPH) trades at $0.30 with AI Score 50/100 (Grade B). UpHealth, Inc. is a digital health services company focused on providing patient-centric technologies and services. Market cap: $5.33M, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for UPH: UPH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UPH against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
UPH: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
UpHealth, Inc. (UPH) Healthcare & Pipeline Overview
UpHealth, Inc. delivers digital health technologies and services, focusing on integrated care management, virtual care infrastructure, and pharmacy solutions. The company's integrated platforms and tech-enabled services aim to improve patient care and integrate healthcare delivery across various settings, operating in a competitive healthcare information services market.
What Is the Investment Thesis for UPH?
UpHealth, Inc. presents a compelling, albeit high-risk, investment case within the digital health services sector. The company's focus on integrated care management, virtual care infrastructure, and pharmacy services positions it to capitalize on the growing demand for telehealth and remote patient monitoring. However, the company's negative profit margin of -140.4% raises concerns about its financial sustainability. Key value drivers include the expansion of its Syntranet Core Platform and the growth of its virtual care services through Cloudbreak and HelloLyf. Upcoming catalysts include potential partnerships with healthcare providers and payers to expand its market reach. Investors should closely monitor the company's ability to improve its profitability and manage its operating expenses. The company's beta of 0.51 indicates lower volatility compared to the market.
Based on FMP financials and quantitative analysis
UPH Key Highlights
- Market capitalization of $5.33M, reflecting its small-cap status.
- Negative P/E ratio of -0.02, indicating current unprofitability.
- Gross margin of 44.2%, suggesting potential for profitability if operating expenses are managed effectively.
- Beta of 0.51, indicating lower volatility compared to the overall market.
- Operates in the digital health services market, which is experiencing significant growth due to increasing adoption of telehealth and remote patient monitoring.
Who Are UPH's Competitors?
UPH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GBNH Greenbrook TMS Inc. | $0.12 | -40.69% | $5.52M | 45 |
| LMDX LumiraDx Limited | $0.02 | +0.00% | $5.10M | 46 |
| NSTG NanoString Technologies, Inc. | $0.11 | -37.43% | $5.07M | 51 |
| NUVO Holdco Nuvo Group D.G Ltd. Ordinary Shares | $0.17 | +100.00% | $5.65M | 49 |
| CMHSF Comprehensive Healthcare Systems, Inc. | $0.34 | +0.00% | $6.22M | 55 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| CMPD CompuMed, Inc. | $6.70 | -0.30% | $8.64M | 60 |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are UPH's Key Strengths?
- Integrated platform offering a comprehensive suite of digital health solutions.
- Established relationships with healthcare providers and payers.
- Proprietary technology and intellectual property.
- Patient-centric approach to healthcare delivery.
What Are UPH's Weaknesses?
- Negative profit margin (-140.4%) raises concerns about financial sustainability.
- Small market capitalization ($0.01 billion) limits access to capital.
- Intense competition in the digital health services market.
- Reliance on acquisitions for growth.
What Could Drive UPH Stock Higher?
- Expansion of Syntranet Core Platform to new healthcare providers and payers.
- Growth of virtual care services through Cloudbreak and HelloLyf platforms.
- Potential partnerships with healthcare organizations to integrate UpHealth's solutions.
- Development and launch of new digital health solutions for specific disease areas.
What Are the Key Risks for UPH?
- Financial-distress signal — its Altman Z-Score of -4.08 sits in the distress zone (elevated bankruptcy risk).
- Intense competition in the digital health services market.
- Regulatory changes and evolving healthcare policies.
- Cybersecurity risks and data privacy concerns.
- Negative profit margin and financial sustainability concerns.
What Are the Growth Opportunities for UPH?
- Expansion of Syntranet Core Platform: UpHealth can grow by expanding the capabilities and reach of its Syntranet Core Platform, an integrated care management platform. This platform can be enhanced with AI-driven analytics and personalized care plans to improve patient outcomes and reduce healthcare costs. The market for care management platforms is estimated to reach $30 billion by 2028, providing a significant growth opportunity for UpHealth. Timeline: Ongoing.
- Growth of Virtual Care Services: UpHealth can capitalize on the increasing demand for virtual care services through its Cloudbreak and HelloLyf platforms. These platforms can be expanded to offer a wider range of telehealth services, including remote patient monitoring, chronic disease management, and mental health support. The global telehealth market is projected to reach $55 billion by 2027, offering substantial growth potential. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers and Payers: UpHealth can accelerate its growth by forming strategic partnerships with healthcare providers and payers. These partnerships can provide access to a larger patient base and enable the integration of UpHealth's solutions into existing healthcare workflows. The market for healthcare partnerships is growing as healthcare organizations seek to improve efficiency and patient care. Timeline: Ongoing.
- Geographic Expansion: UpHealth can expand its geographic reach by targeting new markets and regions. This can be achieved through strategic acquisitions, partnerships, and organic growth. The global digital health market is expanding rapidly, with significant opportunities in emerging markets. Timeline: Ongoing.
- Development of New Digital Health Solutions: UpHealth can drive growth by developing new digital health solutions that address unmet needs in the healthcare market. This can include solutions for specific disease areas, such as diabetes, cardiovascular disease, and mental health. The market for digital health solutions is constantly evolving, with new technologies and innovations emerging regularly. Timeline: Ongoing.
What Opportunities Does UPH Have?
- Expansion of Syntranet Core Platform and virtual care services.
- Strategic partnerships with healthcare providers and payers.
- Geographic expansion into new markets.
- Development of new digital health solutions.
What Threats Does UPH Face?
- Increasing competition from established players in the healthcare industry.
- Regulatory changes and evolving healthcare policies.
- Cybersecurity risks and data privacy concerns.
- Economic downturn and reduced healthcare spending.
What Are UPH's Competitive Advantages?
- Integrated platform offering a comprehensive suite of digital health solutions.
- Established relationships with healthcare providers and payers.
- Proprietary technology and intellectual property.
What Does UPH Do?
UpHealth, Inc., headquartered in Delray Beach, Florida, operates as a digital health services company. It was founded with the vision of transforming healthcare delivery through patient-centric digital health technologies and tech-enabled services. The company focuses on managing health and integrating care across three primary areas: integrated care management, virtual care infrastructure, and pharmacy services. UpHealth's evolution has been marked by the development and acquisition of various platforms and solutions designed to address different aspects of the healthcare ecosystem. These include the Syntranet Core Platform, an integrated care management platform; Cloudbreak, a provider of unified telemedicine solutions and digital health tools; HelloLyf from Glocal, a platform delivering primary care and specialty consultations; and MedQuest Pharmacy, a full-service retail and compounding pharmacy that dispenses medications directly to patients. UpHealth aims to provide comprehensive and coordinated care through its integrated digital health solutions, targeting healthcare providers, payers, and patients. The company competes with other players in the healthcare information services market by offering a range of digital health solutions.
What Products and Services Does UPH Offer?
- Provides an integrated care management platform called Syntranet Core Platform.
- Offers unified telemedicine solutions and digital health tools through Cloudbreak.
- Delivers primary care and specialty consultations via the HelloLyf platform.
- Operates MedQuest Pharmacy, a full-service retail and compounding pharmacy.
- Integrates digital health technologies to manage health and integrate care.
- Offers patient-centric digital health services.
How Does UPH Make Money?
- Generates revenue through subscriptions to its Syntranet Core Platform.
- Earns fees from telemedicine consultations and digital health tools provided through Cloudbreak and HelloLyf.
- Derives revenue from the sale of prescription medications through MedQuest Pharmacy.
What Industry Does UPH Operate In?
UpHealth, Inc. operates within the rapidly evolving healthcare information services industry. The industry is driven by the increasing adoption of digital health technologies, telehealth, and remote patient monitoring. The market is competitive, with players like GBNH, HLTHQ, LMDX, NSTG, and NUVO offering various digital health solutions. UpHealth aims to differentiate itself through its integrated care management platform and comprehensive suite of virtual care services. The industry is expected to continue growing as healthcare providers and payers seek to improve patient outcomes, reduce costs, and enhance access to care.
Who Are UPH's Key Customers?
- Healthcare providers seeking to improve care management and patient outcomes.
- Payers looking to reduce healthcare costs and enhance access to care.
- Patients seeking convenient and affordable access to healthcare services.
How UpHealth, Inc. Is Valued
UpHealth, Inc. carries a market capitalization of $5.33M, placing it in the micro-cap category. Relative to its peer group, UPH's quantitative score of 50/100 is roughly in line with the peer average of 49/100.
Company Profile
UpHealth, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Delray Beach, US. The company is led by CEO Martin S. A. Beck. UPH has traded publicly since 2019.
Key Financial Metrics
Return on assets is -65.6%, showing how much profit it generates from its asset base. A current ratio of 0.63 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 4/9Financial Health
UpHealth, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -4.08 places it in the distress zone, a signal of elevated financial risk.
UPH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- UpHealth's recent insider buying suggests those in the know see long-term value, even if the market hasn't caught on yet.
- The community buzz seems to be cautiously optimistic about UpHealth's expansion into telehealth solutions, seeing potential in the growing market.
- Some traders believe UpHealth is undervalued, with its current market perception not reflecting its potential in digital healthcare.
- There's a growing sentiment that UpHealth's restructuring efforts could streamline operations and improve profitability.
Bear Case
- Community sentiment shows concerns about UpHealth's ability to scale effectively and compete with established players.
- Recent market developments have raised doubts about UpHealth's long-term financial stability, fueling bearish sentiment.
- Some traders are worried about the company's high debt load and its impact on future growth potential.
- The overall market perception of UpHealth is still negative, with many viewing it as a risky investment despite recent efforts to turn things around.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
UPH Latest News
No recent news available for UPH.
UPH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for UPH.
Price Targets
Wall Street price target analysis for UPH.
UPH MoonshotScore
What does this score mean?
The MoonshotScore rates UPH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Martin S. A. Beck
Unknown
Information on Martin S. A. Beck's specific background, career history, education, and previous roles is not available in the provided data. Therefore, a detailed biography cannot be constructed. Further research would be needed to provide a comprehensive profile.
Track Record: Information on Martin S. A. Beck's key achievements, strategic decisions, and company milestones under their leadership is not available in the provided data. Therefore, a detailed track record cannot be constructed. Further research would be needed to provide a comprehensive assessment.
UpHealth, Inc. Healthcare Stock: Key Questions Answered
What does the AI Score mean for UPH?
UPH holds an AI Score of 50/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. UpHealth, Inc. is a digital health services company focused on providing patient-centric technologies and services. They operate in integrated care management, virtual care infrastructure, …
What does UpHealth, Inc. do?
UpHealth, Inc. operates as a digital health services company, providing patient-centric technologies and tech-enabled services. The company focuses on integrated care management, virtual care infrastructure, and pharmacy services. Its solutions include the Syntranet Core Platform, Cloudbreak, HelloLyf, and MedQuest Pharmacy. UpHealth aims to improve patient outcomes and integrate healthcare delivery through its comprehensive suite of digital health solutions, targeting healthcare providers, payers, and patients.
What are the main risks for UPH?
UpHealth, Inc. faces several risks, including intense competition in the digital health services market, potential regulatory changes and evolving healthcare policies, cybersecurity risks and data privacy concerns, and its negative profit margin. The company's financial sustainability is a key concern, given its current unprofitability. Investors should carefully consider these risks before investing in UpHealth, Inc.
How does UpHealth, Inc. generate revenue in the healthcare sector?
UpHealth, Inc. generates revenue through several streams within the healthcare sector. These include subscription fees for its Syntranet Core Platform, which provides integrated care management solutions. The company also earns revenue from telemedicine consultations and digital health tools offered through Cloudbreak and HelloLyf. Additionally, MedQuest Pharmacy contributes to revenue through the sale of prescription medications directly to patients.
What is UpHealth, Inc.'s strategy for expanding its virtual care services?
UpHealth, Inc.'s strategy for expanding its virtual care services centers around its Cloudbreak and HelloLyf platforms. The company aims to broaden the range of telehealth services offered, including remote patient monitoring, chronic disease management, and mental health support. Strategic partnerships with healthcare providers and payers are also crucial for expanding its reach and integrating its solutions into existing healthcare workflows.
What are the key factors to evaluate for UPH?
UpHealth, Inc. (UPH) holds an AI score of 50/100 (moderate). Not financial advice.
How frequently does UPH data refresh on this page?
UPH's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven UPH's recent stock price performance?
UpHealth, Inc. (UPH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated platform offering a comprehensive suite of digital health solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UPH overvalued or undervalued right now?
UpHealth, Inc. (UPH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for UPH, limiting assessment.
- CEO profile information incomplete.